MyChesCo on MSN5h
Johnson & Johnson Highlights Promising Data on Investigational Autoantibody Drug Nipocalimab
Johnson & Johnson has unveiled groundbreaking findings on nipocalimab, an investigational FcRn blocker, in a recent ...
ksn.com8h
Ellsworth woman raising awareness to rare neuromuscular disease
A woman from Ellsworth is navigating life with a rare neuromuscular disease. Tina Bruning learned of her diagnosis of Generalized Myasthenia Gravis or gMG in May of 2021.
The American Journal of Managed Care3d
Nipocalimab’s Promising Potential in Advancing gMG Care
For part 3 of our interview with Katie Abouzahr, MD, Johnson & Johnson Innovative Medicine, we discuss the favorable safety ...